Cowen analyst Gary Taylor raised the firm’s price target on HCA Healthcare to $292 from $238 and keeps an Outperform rating on the shares. The analyst modestly tweaked assumptions for pricing labor costs, other OpEx inflation, and EBITDA and as a result lowered 2023-25 EBITDA.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on HCA: